Friday, October 23, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 20, 2026

Intel's AI Comeback: CEO Reveals Insatiable CPU Demand As Customers Bulk Up Orders

View original at finance.yahoo.com
Intel's AI Comeback: CEO Reveals Insatiable CPU Demand As Customers Bulk Up Orders Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Intel improved 18A yields with monthly progress of 7% to 8%, helping attract outside customer interest in Intel's foundry

    60% confidence
  • Intel rated Neutral with a price target of $124.00

    60% confidence
  • One customer wanted to triple its CPU forecast, but Intel needs several quarters to catch up to meet that demand

    60% confidence
  • Google is an important partner and Intel wants to work with 'winners' by helping customers succeed

    60% confidence
  • Intel's foundry business is a strategic national asset because more than 90% of advanced processors are made outside the U.S.

    60% confidence
  • Intel's 14A process could reach risk production in 2028 and volume production in 2029, on a timeline to compete with TSMC

    60% confidence
  • Intel is simplifying its roadmap, bringing engineering closer to customers, and rebuilding talent to restore competitiveness

    60% confidence
  • Multiple customers are working with Intel on foundry services (declined to name Apple but implied its inclusion)

    60% confidence
  • Intel's XPU combined with SambaNova's data-flow architecture can deliver better performance and lower power consumption

    60% confidence
  • Intel rated Buy with a price target of $140.00

    60% confidence
  • Intel once led the data center market but lost that position after product and execution mistakes

    60% confidence
  • AI inference is increasing CPU demand as customers need more processors to manage orchestration, agents, and reinforcement learning

    60% confidence
  • Intel rated Buy with a price target of $130.00

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,426 source documents archived
Query this data → isubstrate.com